Ex vivo SARS-CoV-2 infection of human lung reveals heterogeneous host defense and therapeutic responses.
Schaller MA, Sharma Y, Dupee Z, Nguyen D, Urueña J, Smolchek R, Loeb JC, Machuca TN, Lednicky JA, Odde DJ, Campbell RF, Sawyer WG, Mehrad B.
Schaller MA, et al.
JCI Insight. 2021 Sep 22;6(18):e148003. doi: 10.1172/jci.insight.148003.
JCI Insight. 2021.
PMID: 34357881
Free PMC article.